CDKN2A and breast carcinoma: In a similar way, a correlation between CDKN2A expression and telomere length has also been described in patients with breast cancer, in whom repression of CDKN2A/RB1 and/or TP53/CDKN1A by hypermethylation was associated with greater telomere shortening.